CAYUGA BIOTECH
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
CAYUGA BIOTECH
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2015-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.cayugabiotech.com
Total Employee:
11+
Status:
Active
Total Funding:
250 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content Google Apps For Business
Current Employees Featured
Founder
Investors List
SOSV
SOSV investment in Seed Round - Cayuga Biotech
IndieBio
IndieBio investment in Seed Round - Cayuga Biotech
SOSV
SOSV investment in Convertible Note - Cayuga Biotech
IndieBio
IndieBio investment in Convertible Note - Cayuga Biotech
IndieBio
IndieBio investment in Seed Round - Cayuga Biotech
SOSV
SOSV investment in Seed Round - Cayuga Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-03 | Cayuga Biotech Appoints Andrea Ashford-Hicks as Chief Executive Officer |
Official Site Inspections
http://www.cayugabiotech.com
- Host name: premium80-5.web-hosting.com
- IP address: 199.188.200.253
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
